Pharma

Adopt Structured Asset
Policies for Pharma

Pharmaceutical companies operate under some of the strictest regulatory standards in the world — and asset management gaps can translate directly into compliance failures. Levantare combines specialist asset management services with Smart Assets Pro to ensure every piece of equipment is tracked, maintained, and audit-ready, so your team stays focused on what matters most.

Pharma & Life Sciences

Regulatory Compliance

Real-Time Tracking

Cloud-Based

$10M–$100M

the average total cost of a single pharmaceutical product recall, once retrieval, disposal, litigation, and resulting business interruption are included.

Source: FDA / Life Sciences Recall Cost Analysis

470

warning letters issued by the FDA in a single year, with equipment maintenance and documentation remaining a recurring cause.

Source: FDA Enforcement Data

Trillions of Dollars

lost every year to controlled-drug diversion where inventory and asset visibility are weak.

Source: National Drug Intelligence Center

~35%

typical capital equipment utilization at biopharmaceutical organizations, leaving many costly instruments underused.

Source: McKinsey

~5 hrs/week

spent by pharmacists and QA teams reconciling controlled-drug paperwork manually.

Source: Hospital Drug Diversion Industry Data

Millions of Dollars

lost annually through recalls, diversion, idle laboratory equipment, and audit failures—the hidden cost poor asset visibility adds to the business.

Source: Industry Benchmark

See What's Underperforming. Act on It Immediately.

Eliminate Unused Assets

Performance Metrics Asset Utilization Reports Regular Audits

Underutilized assets quietly drain budgets. Without the right reporting, they remain invisible. Smart Assets delivers performance metrics, seamless integrations, and scheduled audits in one comprehensive platform.

Analyze. Identify. Optimize. All in one place.

Complete Records. Instant Access. No Searching.

Maintain an Asset Database with Ease